Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Urology Case Reports|November 29, 2023
A new method for effective use of the ClearPetra ureteral access sheath for a giant ureteral stoneTomoya Nao, Ryohei Iga, Rie Yoshimura, et al.IJU Case Reports|March 6, 2023
A case of acute lymphocytic gastritis related to treatment with pembrolizumab for metastatic urothelial carcinomaYousuke Fukiishi, Hideo Fukuhara, Yoshitaka Kurano, et al.IJU Case Reports|January 9, 2026
Severe Pelvic Organ Prolapse Managed Without Surgery: Pessary Discontinued After Pelvic Floor Muscle Training With M-Mode UltrasoundYukimasa Ide, Nobutaka Shimizu, Rio Ninomiya, et al.IJU Case Reports|April 30, 2024
Autologous rectus abdominis fascia sling surgery following unsuccessful synthetic midurethral slingYoshitaka Kurano, Nobutaka Shimizu, Rie Yoshimura, et al.Lower Urinary Tract Symptoms|August 4, 2026
Early Physiologic Deobstruction After 980-nm Diode-Laser Contact Prostate Vaporization: Analysis of Evaluable Paired Pressure-Flow Studies From a Consecutive CohortYoshitaka Kurano, Nobutaka Shimizu, Yukimasa Ide, et al.Journal of Medical Case Reports|November 19, 2025
Successful treatment of large-cell neuroendocrine carcinoma of the prostate with pembrolizumab: a case reportErika Yamashita, Shingo Ashida, Rie Yoshimura, et al.Photodiagnosis and Photodynamic Therapy|February 2, 2026
Clinical Outcomes Following Transurethral Laser Ablation with Topical Versus General or Spinal Anesthesia for Non-Muscle-Invasive Bladder Cancer: A Japanese Single-Center Pilot StudyShinkuro Yamamoto, Satoshi Fukata, Sho Shimasaki, et al.Exploration of Targeted Anti-Tumor Therapy|August 1, 2026
Transurethral laser ablation using 980-nm diode laser for recurrent non-muscle invasive bladder cancerHideo Fukuhara, Syo Shimasaki, Erika Yamashita, et al.European Journal of Medical Research|February 20, 2026
Oral 5‑aminolevulinic acid for overactive bladder: a double‑blind, randomized, placebo‑controlled pilot trialSatoshi Fukata, Nobutaka Shimizu, Takahira Kuno, et al.IJU Case Reports|September 5, 2025
Successful Management of Tumor Lysis Syndrome Following Enfortumab Vedotin Plus Pembrolizumab Therapy in Metastatic Urothelial Carcinoma: A Case ReportDaigo Takemori, Ryu Shigehisa, Sho Shimasaki, et al.Pageof 2